Brian T. Powl

Companies

• Kura OncologyChief Commercial Officer Aug 16, 2023 to now¹
• Fate TherapeuticsChief Commercial Officer Jun 29, 2022 to Jul 6, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KOKura Oncology KURA136,819 shares³$1.3M at $9.21Sep 29, 2026
• FTFate Therapeutics FATE41,146 shares⁴$77.4K at $1.88Jul 5, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 29, 2026Sold 15,430 shares at $10.75 of Kura Oncology³
• Sep 28, 2026Sold 8,000 shares at $10.56 of Kura Oncology³
• Sep 28, 2026Sold 9,020 shares at $10.50 of Kura Oncology³
• Aug 21, 2026Sold 4,345 shares at $11.89 of Kura Oncology⁵
• May 21, 2026Sold 10,000 shares at $11.00 of Kura Oncology⁶
• May 19, 2026Sold 339 shares at $9.21 of Kura Oncology⁷
• Jan 27, 2026Sold 1,572 shares at $8.46 of Kura Oncology⁸
• Jan 27, 2026Sold 4,842 shares at $8.46 of Kura Oncology⁸
• Jan 2, 2026Granted 50,000 shares of Kura Oncology⁹
• Nov 14, 2025Sold 8,887 shares at $11.18 of Kura Oncology¹⁰
• Nov 13, 2025Granted 48,900 shares of Kura Oncology¹⁰
• Sep 29, 2025Sold 8,891 shares at $8.94 of Kura Oncology¹¹
• Sep 27, 2025Granted 48,900 shares of Kura Oncology¹¹
• Jan 28, 2025Sold 1,583 shares at $7.87 of Kura Oncology¹²
• Jan 2, 2025Granted 46,250 shares of Kura Oncology¹³
• Jan 2, 2024Granted 15,000 shares of Kura Oncology¹⁴
• Jul 5, 2023Sold 3,854 shares at $4.87 of Fate Therapeutics⁴
• Jun 27, 2022Granted 45,000 shares of Fate Therapeutics¹⁵